5-FLUOROURACILdrug master file held by dcs pharma
EU-GMP, CEP AND COMPLETE DMF/US-DMF AVAILABLE
THERAPEUTIC INDICATION: ONCOLOGY
5-Fluorouracil is one of the most prescribed cytostatics used mainly for the treatment of colorectal and breast cancer.
Originator: HOFFMANN LA ROCHE
Core patent exclusivities: 1962 off patent
- DCS Pharma is the DMF holder
- We organize the supply chain of the starting material 2EFU and the packaging material.
- EU-GMP, CEP and full DMF, US-DMF
This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.